Glaxo's Profits Hit New Depth

**Drum roll please

Bloomberg are reporting that GlaxoSmithKline's second- quarter profit slumped by a massive 92%, hurt by costs to settle lawsuits over the Avandia diabetes medicine and the Paxil antidepressant.

That's one hell of a drop for Glaxo's shareholders, earnings dropped to £130 million pounds or 2.6 pence a share, from £1.57 billion pounds, or 31 pence, in the same period a year ago.

Full report on Glaxo's website

Bloomberg article is HERE











and let's not forget...




Fid

ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING